Survey of cancer genetics

Genetic testing implications

Henry T. Lynch, Ramon M. Fusaro, Stephen J. Lemon, Thomas Smyrk, Jane Lynch

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The identification of an increasing variety of 'cancer genes,' thereby signifying the cancer destiny of patients from hereditary cancer families, offer numerous opportunities for cancer surveillance and management, including prophylactic surgery in selected circumstances. This new science and technology has emerged at a rapid pace, making it difficult for many physicians to grasp its full impact. This article reviews the genetics and molecular genetics of cancer and updates its genetic counseling implications. Several hereditary cancer syndromes are reviewed as cancer genetic models, including multiple endocrine neoplasia types 2A and 2B, neurofibromatosis, familial pancreatic carcinoma, familial atypical multiple mole melanoma syndrome, and von Hippel-Lindau disease. Special attention is given to the distinctive pathology features that may appear in certain hereditary cancer syndromes, with hereditary nonpolyposis colorectal carcinoma discussed as a prototypic model. Genetic testing issues including variable positions relevant to whether and/or when to test and whom to test, as well as the position of the American Society of Clinical Oncology, are also discussed.

Original languageEnglish
Pages (from-to)523-532
Number of pages10
JournalCancer
Volume80
Issue number3 SUPPL.
StatePublished - 1997

Fingerprint

Genetic Testing
Hereditary Neoplastic Syndromes
Neoplasms
Multiple Endocrine Neoplasia Type 2b
Dysplastic Nevus Syndrome
Multiple Endocrine Neoplasia Type 2a
von Hippel-Lindau Disease
Neurofibromatoses
Neoplasm Genes
Genetic Models
Genetic Counseling
Molecular Biology
Colorectal Neoplasms
Surveys and Questionnaires
Pathology
Technology
Physicians

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Lynch, H. T., Fusaro, R. M., Lemon, S. J., Smyrk, T., & Lynch, J. (1997). Survey of cancer genetics: Genetic testing implications. Cancer, 80(3 SUPPL.), 523-532.

Survey of cancer genetics : Genetic testing implications. / Lynch, Henry T.; Fusaro, Ramon M.; Lemon, Stephen J.; Smyrk, Thomas; Lynch, Jane.

In: Cancer, Vol. 80, No. 3 SUPPL., 1997, p. 523-532.

Research output: Contribution to journalArticle

Lynch, HT, Fusaro, RM, Lemon, SJ, Smyrk, T & Lynch, J 1997, 'Survey of cancer genetics: Genetic testing implications', Cancer, vol. 80, no. 3 SUPPL., pp. 523-532.
Lynch HT, Fusaro RM, Lemon SJ, Smyrk T, Lynch J. Survey of cancer genetics: Genetic testing implications. Cancer. 1997;80(3 SUPPL.):523-532.
Lynch, Henry T. ; Fusaro, Ramon M. ; Lemon, Stephen J. ; Smyrk, Thomas ; Lynch, Jane. / Survey of cancer genetics : Genetic testing implications. In: Cancer. 1997 ; Vol. 80, No. 3 SUPPL. pp. 523-532.
@article{e823f8cce4f948d2894419afdb1e6cbd,
title = "Survey of cancer genetics: Genetic testing implications",
abstract = "The identification of an increasing variety of 'cancer genes,' thereby signifying the cancer destiny of patients from hereditary cancer families, offer numerous opportunities for cancer surveillance and management, including prophylactic surgery in selected circumstances. This new science and technology has emerged at a rapid pace, making it difficult for many physicians to grasp its full impact. This article reviews the genetics and molecular genetics of cancer and updates its genetic counseling implications. Several hereditary cancer syndromes are reviewed as cancer genetic models, including multiple endocrine neoplasia types 2A and 2B, neurofibromatosis, familial pancreatic carcinoma, familial atypical multiple mole melanoma syndrome, and von Hippel-Lindau disease. Special attention is given to the distinctive pathology features that may appear in certain hereditary cancer syndromes, with hereditary nonpolyposis colorectal carcinoma discussed as a prototypic model. Genetic testing issues including variable positions relevant to whether and/or when to test and whom to test, as well as the position of the American Society of Clinical Oncology, are also discussed.",
author = "Lynch, {Henry T.} and Fusaro, {Ramon M.} and Lemon, {Stephen J.} and Thomas Smyrk and Jane Lynch",
year = "1997",
language = "English",
volume = "80",
pages = "523--532",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "3 SUPPL.",

}

TY - JOUR

T1 - Survey of cancer genetics

T2 - Genetic testing implications

AU - Lynch, Henry T.

AU - Fusaro, Ramon M.

AU - Lemon, Stephen J.

AU - Smyrk, Thomas

AU - Lynch, Jane

PY - 1997

Y1 - 1997

N2 - The identification of an increasing variety of 'cancer genes,' thereby signifying the cancer destiny of patients from hereditary cancer families, offer numerous opportunities for cancer surveillance and management, including prophylactic surgery in selected circumstances. This new science and technology has emerged at a rapid pace, making it difficult for many physicians to grasp its full impact. This article reviews the genetics and molecular genetics of cancer and updates its genetic counseling implications. Several hereditary cancer syndromes are reviewed as cancer genetic models, including multiple endocrine neoplasia types 2A and 2B, neurofibromatosis, familial pancreatic carcinoma, familial atypical multiple mole melanoma syndrome, and von Hippel-Lindau disease. Special attention is given to the distinctive pathology features that may appear in certain hereditary cancer syndromes, with hereditary nonpolyposis colorectal carcinoma discussed as a prototypic model. Genetic testing issues including variable positions relevant to whether and/or when to test and whom to test, as well as the position of the American Society of Clinical Oncology, are also discussed.

AB - The identification of an increasing variety of 'cancer genes,' thereby signifying the cancer destiny of patients from hereditary cancer families, offer numerous opportunities for cancer surveillance and management, including prophylactic surgery in selected circumstances. This new science and technology has emerged at a rapid pace, making it difficult for many physicians to grasp its full impact. This article reviews the genetics and molecular genetics of cancer and updates its genetic counseling implications. Several hereditary cancer syndromes are reviewed as cancer genetic models, including multiple endocrine neoplasia types 2A and 2B, neurofibromatosis, familial pancreatic carcinoma, familial atypical multiple mole melanoma syndrome, and von Hippel-Lindau disease. Special attention is given to the distinctive pathology features that may appear in certain hereditary cancer syndromes, with hereditary nonpolyposis colorectal carcinoma discussed as a prototypic model. Genetic testing issues including variable positions relevant to whether and/or when to test and whom to test, as well as the position of the American Society of Clinical Oncology, are also discussed.

UR - http://www.scopus.com/inward/record.url?scp=0030755547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030755547&partnerID=8YFLogxK

M3 - Article

VL - 80

SP - 523

EP - 532

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 3 SUPPL.

ER -